Pancreatic Cancer Research

ResearcherDartmouth CollegeActive in the last 2 years

Brian William Pogue

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9887-670X; OpenAlex author ID A5089497655; NIH RePORTER profile ID 2210736. Sources: OpenAlex.

Their work

Papers
15 (first author 0, last author 6)
Trials
0
Grants
1
Labs led
1
Collaborators
30
Papers, trials and grants by year

2014: 2 papers · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 2 papers · 2020: 3 papers · 2021: 3 papers · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 grant

Papers 15

  1. Photodynamic priming with red light triggers adaptive immune responses in a pancreatic cancer mouse model. Co-author DOI 10.1016/j.jphotobiol.2025.113126↗
  2. Radiation-Activated Cobalamin-Kinase Inhibitors for Treatment of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1021/acs.molpharmaceut.3c00667↗
  3. Mapping estimates of vascular permeability with a clinical indocyanine green fluorescence imaging system in experimental pancreatic adenocarcinoma tumors. Last author DOI 10.1117/1.jbo.28.7.076001↗
  4. EUS-guided verteporfin photodynamic therapy for pancreatic cancer. Co-author DOI 10.1016/j.gie.2021.02.027↗
  5. CT radiomic features of photodynamic priming in clinical pancreatic adenocarcinoma treatment. Last author DOI 10.1088/1361-6560/ac1458↗
  6. Photodynamic priming with triple-receptor targeted nanoconjugates that trigger T cell-mediated immune responses in a 3D in vitro heterocellular model of pancre… Co-author DOI 10.1515/nanoph-2021-0304↗
  7. Tumor targeting vitamin B12 derivatives for X-ray induced treatment of pancreatic adenocarcinoma. Co-author DOI 10.1016/j.pdpdt.2019.101637↗
  8. High-Resolution Ex Vivo Elastography to Characterize Tumor Stromal Heterogeneity In Situ in Pancreatic Adenocarcinoma. Last author DOI 10.1109/tbme.2019.2963562↗
  9. NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targeting Heterogeneity in Cancer. Co-author DOI 10.3390/jcm9082390↗
  10. Verteporfin- and sodium porfimer-mediated photodynamic therapy enhances pancreatic cancer cell death without activating stromal cells in the microenvironment. Co-author DOI 10.1117/1.jbo.24.11.118001↗
  11. Elastography Can Map the Local Inverse Relationship between Shear Modulus and Drug Delivery within the Pancreatic Ductal Adenocarcinoma Microenvironment. Co-author DOI 10.1158/1078-0432.ccr-18-2684↗
  12. Collagen Complexity Spatially Defines Microregions of Total Tissue Pressure in Pancreatic Cancer. Last author DOI 10.1038/s41598-017-10671-w↗
  13. Perfusion CT estimates photosensitizer uptake and biodistribution in a rabbit orthotopic pancreatic cancer model: a pilot study. Last author DOI 10.1016/j.acra.2014.12.014↗
  14. Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer. Co-author DOI 10.1038/bjc.2014.95↗
  15. CT contrast predicts pancreatic cancer treatment response to verteporfin-based photodynamic therapy. Last author DOI 10.1088/0031-9155/59/8/1911↗

Grants 1

  1. Core A: Administration, Integration, Education and Career Development P01CA084203↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tayyaba Hasan · 11 shared papers, 1 shared grant, 2014–2026 · strength 1.77
  2. Edward V. Maytin · 3 shared papers, 1 shared grant, 2021–2026 · strength 1.09
  3. Bryan Quilty Spring · 1 shared paper, 1 shared grant, 2025–2026 · strength 0.80
  4. Vinay Chandrasekhara · 1 shared paper, 1 shared grant, 2025–2026 · strength 0.80
  5. Kenneth K. Wang MD · 4 shared papers, 2019–2025 · strength 0.62
  6. Stephen Pereira · 1 shared grant, 2026 · strength 0.58
  7. Kenneth K Wang · 1 shared grant, 2026 · strength 0.58
  8. Guillermo J Tearney · 1 shared grant, 2026 · strength 0.58
  9. Brett E Bouma · 1 shared grant, 2026 · strength 0.58
  10. Stephen Pereira · 1 shared grant, 2026 · strength 0.58
  11. Marvin M. Doyley · 4 shared papers, 2017–2023 · strength 0.50
  12. Liberty N. Gendron · 2 shared papers, 2020–2024 · strength 0.38
  13. Jennifer R. Shell · 2 shared papers, 2020–2024 · strength 0.38
  14. Pushpamali De Silva · 2 shared papers, 2021–2025 · strength 0.38
  15. Phuong Vincent · 3 shared papers, 2019–2021 · strength 0.35
  16. Shazia Bano · 2 shared papers, 2020–2021 · strength 0.28
  17. Stephen P. Pereira · 4 shared papers, 2014–2021 · strength 0.27
  18. Matthew S. Reed · 1 shared paper, 2023 · strength 0.22
  19. Mohammad Ahsan Saad · 1 shared paper, 2025 · strength 0.22
  20. Hexuan Wang · 2 shared papers, 2019–2020 · strength 0.21
  21. Michael D. Nieskoski · 2 shared papers, 2017–2020 · strength 0.18
  22. Yuri Hanada · 1 shared paper, 2021 · strength 0.14
  23. Girgis Obaid · 1 shared paper, 2020 · strength 0.13
  24. Jingjing Lu · 1 shared paper, 2019 · strength 0.10
  25. Michael J. Levy · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.